papillomavirus dna
Recently Published Documents


TOTAL DOCUMENTS

1070
(FIVE YEARS 59)

H-INDEX

76
(FIVE YEARS 5)

2021 ◽  
Vol 10 (21) ◽  
pp. 5209
Author(s):  
Kamylla Conceição Gomes do Nascimento ◽  
Élyda Gonçalves de Lima ◽  
Zhilbelly da Mota Nunes ◽  
Marconi Rêgo Barros ◽  
Marcus Vinícius de Aragão Batista ◽  
...  

This study evaluated the presence of Human Papillomavirus (HPV) DNA in the cervix and peripheral blood of women with cervical intraepithelial neoplasia (CIN I, II, and III) and healthy individuals. Overall, 139 paired peripheral blood and cervix samples of healthy women and women with CIN I, II, and III (n = 68) were tested for HPV DNA by using standard procedures. Polymerase chain reaction (PCR) sequencing determined HPV types. Quantification of HPV16 E6 and E2 genes was performed to determine viral load and physical state. HPV DNA was detected in the cervix (21.1% in healthy individuals; 48.8–55.5% in CIN patients), blood (46.4% in healthy individuals; 44.1–77.7% in CIN patients) and paired peripheral blood and cervix samples (24% in healthy individuals; 32.5–44.4% in CIN patients). The most frequent types found in the cervix were HPV16, 18, 31, 33, 58, and 70, while HPV16, 18, 33, 58, and 66 were the most frequent types found in the blood. HPV DNA in the cervix was associated with previous sexually transmitted infections (STIs) (p = 0.023; OR: 2.978; CI:1.34–7.821), HPV DNA in the blood (p = 0.000; OR: 8.283; CI:3.700–18.540), and cervical lesions (CIN I/II or III) (p = 0.007). Binomial logistic regression showed that HPV DNA in the blood (p = 0.000; OR: 9.324; CI:3.612–24.072) and cervical lesions (p = 0.011; OR: 3.622; CI:1.338–9.806) were associated with HPV DNA in the cervix. However, we did not find an association between HPV DNA in the blood and cervical lesions (p = 0.385). Our results showed that only HPV DNA found in the cervix was associated with cervical lesions.


2021 ◽  
Author(s):  
Marcin Przybylski ◽  
Dominik Pruski ◽  
Sonja Millert-Kalinska ◽  
Radoslaw Madry ◽  
Malgorzata Lagiedo-Zelazowska ◽  
...  

2021 ◽  
Vol 32 ◽  
pp. S757-S758
Author(s):  
M. McMullen ◽  
L. Avery ◽  
J. Zou ◽  
Z. Zhao ◽  
A. Tesfu ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Maria Teresa Bruno ◽  
Salvatore Caruso ◽  
Francesca Bica ◽  
Giulia Arcidiacono ◽  
Sara Boemi

Abstract Background It is believed that HPV infection can result in the death of placental trophoblasts and cause miscarriages or preterm birth. In clinical cases of placental villi positive for HPV DNA reported by other authors, contamination is suspected in the act of crossing the cervical canal. We analyzed placental samples of women who resorted to elective abortion obtained by hysterosuction of ovular material, bypassing any contact with the cervical canal and vagina. Methods We studied the chorionic villi of the placenta of 64 women who resorted to voluntary termination of pregnancy, in the first trimester. To avoid contamination of the villi by the cervical canal, we analyzed placental samples obtained by hysterosuction of ovular material, bypassing any contact with the cervical canal and vagina. All samples of chorionic villi were manually selected from the aborted material and subjected to research for HPV DNA. Results HPV DNA was detected in 10 out of 60 women (16.6%). The HPV DNA identified in the placenta belonged to genotypes 6, 16, 35, 53, and 90. Conclusion The study shows that papillomavirus DNA can infect the placenta and that placenta HPV infection can occur as early as the first trimester of pregnancy.


Sign in / Sign up

Export Citation Format

Share Document